Werewolf Therapeutics, Inc.·4

May 4, 4:31 PM ET

Leonard Reid 4

4 · Werewolf Therapeutics, Inc. · Filed May 4, 2021

Insider Transaction Report

Form 4
Period: 2020-12-08
Leonard Reid
Chief Operating Officer
Transactions
  • Award

    Stock Option (right to buy)

    2021-04-30+27,31127,311 total
    Exercise: $16.00Exp: 2031-04-29Common Stock (27,311 underlying)
  • Award

    Stock Option (right to buy)

    2020-12-08+99,16399,163 total
    Exercise: $4.77Exp: 2030-12-07Common Stock (99,163 underlying)
Footnotes (2)
  • [F1]The option was granted on December 8, 2020. 25% of the shares underlying the options vest on December 8, 2021, the remaining shares vest in equal monthly installments through December 8, 2024.
  • [F2]The option was granted on April 30, 2021. The shares underlying the option vest over four years in equal monthly installments through April 30, 2025.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION